Teva Clonidine Transdermal System Recall: Impurities May Cause Harm

Take action

Contact the company & request your remedy

Recalling firmTeva Pharmaceuticals USA400 Interpace Pkwy, N/A · Parsippany, NJ 07054-1120

No email on file — write to the address above instead.

✎ GovInfoNow plain-language explainer

What happened, in plain English

Teva Pharmaceuticals USA is recalling Clonidine Transdermal System patches (0.1 mg/day) because they may contain impurities or degrade improperly. This could lead to health risks if used as directed.

Why it’s dangerous

The patches may have impurities or degrade improperly, which could lead to health risks if used as directed. This is a quality control issue in the manufacturing process.

Who’s affected

People with prescriptions for Clonidine Transdermal System patches (0.1 mg/day) from the recall lot. Those using the product without a prescription are not affected.

How to tell if you have this one

Check for the NDC code 0591-3508-04 and lot number 1369117B on the packaging. The product is prescription-only and distributed by Actavis Pharma, Inc.

Brand
Teva Pharmaceuticals USA
Category
Drug

Based on the official FDA remedy

What to do — step by step

Check Product Details
Look for NDC 0591-3508-04 and lot number 1369117B on the packaging.

✎ GovInfoNow

Questions people ask

Is this product safe to use?

The product may contain impurities or degrade improperly, which could lead to health risks. It is not safe to use as recalled.

How do I know if I have the recalled product?

Check for NDC 0591-3508-04 and lot number 1369117B on the packaging. The product is prescription-only.

What should I do if I have the recalled product?

The recall does not specify a remedy, so contact your healthcare provider for guidance.

Take action

Contact Teva Pharmaceuticals USA

We’ve drafted a message you can send Teva Pharmaceuticals USA to request your refund or repair — edit it as you like.

✉️ Open in email

Subject: Recall D-0235-2022 — Teva Pharmaceuticals USA Teva Pharmaceuticals USA

Hello,

I own a Teva Pharmaceuticals USA that is covered by recall D-0235-2022 from Teva Pharmaceuticals USA.

I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this?

Thank you.

Similar recalls

From people who’ve dealt with this

Experiences, tips, and questions from readers. Every comment is reviewed before it appears.

No comments yet — be the first to share your experience.

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

Official source: FDA Recall #D-0235-2022 (October 28, 2021) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0235-2022 to see it in context.
Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.

Teva Pharmaceuticals USA recalls Clonidine Transdermal System, USP 0.1 mg/day, 4 patches per carton, Rx only, Manufactured by: Actavis Laboratories, UT

Lower-risk recall